Insight Capital
20
11M
15
2.50
3
0.20
- Stages of investment
- Areas of investment
Summary
Insight Capital appeared to be the VC, which was created in 2016. The main department of described VC is located in the Beijing. The fund was located in Asia if to be more exact in China.
Among the most popular fund investment industries, there are Education, Health Care. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Ackerman Boitech. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.
The important activity for fund was in 2018. Deals in the range of 1 - 5 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 6 percentage points less often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year.
Besides them, we counted 1 critical employee of this fund in our database.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the Insight Capital, startups are often financed by Puhua Capital, Green Pine Capital Partners, Gene Capital. The meaningful sponsors for the fund in investment in the same round are Yizhuang Biomedical Mergers and Acquisition Funds, THG Ventures, Qiming Venture Partners. In the next rounds fund is usually obtained by Yizhuang Biomedical Mergers and Acquisition Funds, THG Ventures.
Investments analytics
Analytics
- Total investments
- 20
- Lead investments
- 3
- Rounds per year
- 2.50
- Follow on index
- 0.20
- Investments by industry
- Health Care (12)
- Medical (10)
- Medical Device (5)
- Biotechnology (4)
- Manufacturing (3) Show 8 more
- Investments by region
-
- China (19)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Group Appearance index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Dearer Medical | 01 May 2021 | Medical Device, Medical, Eyewear | Early Stage Venture | 64M | Shanghai, Minhang, China |
| Sigma Squares Tech | 28 Jun 2021 | Enterprise, Manufacturing | Early Stage Venture | 10M | Beijing, Dongcheng District, China |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.